Norris Medicines Ltd holds 35th AGM via VC

Norris Medicines Limited conducted its 35th Annual General Meeting (AGM) on Tuesday, September 29, 2026, via Video Conferencing. The meeting, which commenced at 2:30 PM IST and concluded at 2:45 PM IST, addressed several key agenda items. These included the adoption of Audited Financial Statements for the year ended March 31, 2026, the re-appointment of a director retiring by rotation, and special business concerning the appointment of Mr. Vimal D. Shah as Managing Director. Additionally, resolutions were passed regarding an increase in borrowing limits, authorization for the disposal of the company's undertaking, and enhancement of limits under Section 186 of the Companies Act, 2013. The results of the e-voting will be announced within two working days.